Sundaram Preethi — SEC Form 4 filings
SEC reporting owner CIK 1872422. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-16 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 3,924 shares, $103,649 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
- Largest priced transaction: sale of 2,324 shares @ $26.41 ($61,377) in CATALYST PHARMACEUTICALS, INC., filed 2025-06-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Strategy Officer | 10 | — | 2 legs · 3,924 sh · $103,649 | 35 |
Form 4 filings — Sundaram Preethi
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Disposition to issuer (D): 54,804 @ $31.50 · Disposition to issuer (D): 225,000 (derivative) @ $0 · Disposition to issuer (D): 67,500 (derivative) @ $0 · Disposition to issuer (D): 68,000 (derivative) @ $0 · Disposition to issuer (D): 143,193 (derivative) @ $0 · Disposition to issuer (D): 137,553 (derivative) @ $0 · +4 more | EDGAR |
| 2025-12-30 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 6,667 · Tax withholding (F): 2,369 · Option exercise (M): 6,667 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 6,855 · Tax withholding (F): 1,669 · Option exercise (M): 6,855 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 5,603 · Tax withholding (F): 1,364 · Grant/award (A): 106,873 (derivative) @ $0 · Grant/award (A): 32,257 (derivative) @ $0 · Option exercise (M): 5,603 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Sale (S): 2,324 @ $26.41 · Sale (S): 1,600 @ $26.42 | EDGAR |
| 2025-02-19 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 16,667 · Tax withholding (F): 5,965 · Option exercise (M): 16,667 (derivative) @ $0 | EDGAR |
| 2024-12-31 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 6,667 · Tax withholding (F): 2,345 · Option exercise (M): 6,667 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 6,855 · Tax withholding (F): 2,415 · Option exercise (M): 6,855 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Grant/award (A): 137,553 (derivative) @ $0 · Grant/award (A): 16,809 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 16,667 · Tax withholding (F): 6,025 · Option exercise (M): 16,667 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1872422 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →